- Strong match: 3 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
Back to StakeholdersPrimary Community Link Centre of the Heart Fungi Academy Mindspace SCPTR
Categories
4 domains / 10 areas / 8 specializations
MAPS
Data updated
12 Trials2 Papers
MAPS, the Multidisciplinary Association for Psychedelic Studies, is a U.S.-based 501(c)(3) nonprofit research and educational organization founded in 1986. It works nationally and with a broader global audience to develop medical, legal, and cultural contexts for the careful use of psychedelics and marijuana. Its core activities include research, education, advocacy, and convening the field through large public events.
In psychedelic medicine and policy, MAPS positions itself as an advocate for legal access, drug policy reform, harm reduction, and health equity. Its Policy & Advocacy work includes legislative advocacy, community organizing, and impact litigation, and it has also launched work on access for system-impacted people and broader health equity in the legal psychedelic ecosystem. Current documented initiatives include the Psychedelic Science conference series, the Health Equity Program, The Zendo Project, and Ask MAPS, which handles public inquiries about therapy, research, and policy reform.
IntroductoryHybridMid costPsychedelic-assisted therapy trainingHarm reductionAcademic programmeContinuing educationOtherCurious publicAspiring practitionersLicensed cliniciansFacilitatorsResearchersOther
Blossom’s read
MAPS is a significant and historically influential player in psychedelic education, but it is not a neutral commercial training school. Its strongest fit is for clinicians, researchers, and first responders who want to learn from the organisation that helped define the modern MDMA-assisted therapy model and who are comfortable with a distinctly MAPS lineage. It sits near the centre of the field rather than on the fringes, though its therapy model and internal practices have also attracted criticism and scrutiny, so buyers should read it as an influential but debated source rather than a universally endorsed standard.
Who MAPS is for
Best suited to mental health professionals, first responders, and curious learners who want MAPS-specific education on psychedelics, crisis response, or therapist development. The deeper therapist education appears aimed at authorised clinicians who can legally provide therapy or conduct research in their jurisdiction.
Prerequisites
For the international therapist education programmes, MAPS says eligible mental healthcare providers must be authorised to conduct therapy in their country or conduct research in an MDMA-assisted therapy clinical trial according to local regulations. The introductory Psychedelic Fundamentals course appears open to newcomers and does not state formal prerequisites.
Accreditation & recognition
MAPS has offered CME/CE credit for some conference-style educational activities, with at least one MAPS CME page stating AMA PRA Category 1 Credits were available through CME Consultants and that psychology CE was co-sponsored by the Spiritual Competency Resource Center. I did not find evidence on the current course pages that the present online courses or therapist education programmes are accredited, certified, or carry formal credit.
Cost
The Psychedelic Fundamentals page describes lifetime access and a full refund if the course is not right for the learner, but the page excerpt I found does not show a price. Older MAPS CME material shows a separate CME fee of $125 for that activity, but that was for a conference education event, not necessarily the current catalogue.
What you walk away with
Learners can expect a MAPS-branded grounding in psychedelic history, science, clinical research, therapeutic uses, harm reduction, and, for professional tracks, the inner-directed therapeutic approach, session preparation, medication, integration, and crisis topics such as touch, suicidal ideation, and transference. The outcome is primarily competency-building and professional orientation rather than a clearly advertised standalone licence or universally portable credential.
Non-Clinical Facilitation Snapshot
Retreat OrganizationsOrganization Model
Retreat Center Operator
Organization Status
Active
Facilitation Status
Active Facilitation Services
Access Posture
Unknown / Unclear
Community Networks & Outreach Snapshot
Organization Model
Not set
Organization Status
Not set
Psychedelic Focus
Not set
Last Verified
Apr 17, 2026
Engagement Channels
Engagement channels not set yet.
Audience Focus
Audience focus not set yet.
Verification
Verified
Jurisdiction
Not set
Coverage
Coverage not set
Verification Notes
Seeded from curated community.xlsx list; requires source-level verification pass. Wave 3 web verification (2026-04-17): detected terms [psychedelic, psychedelics, ayahuasca, ibogaine, mdma, harm reduction, community, peer support] on https://maps.org/.
Reimbursement & Market Access Snapshot
This stakeholder is tagged in Reimbursement & Market Access, but profile details have not been added yet.
Similar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 2 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 4 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
Quick Facts
- Type
- nonprofit
- Website
- Visit